- Home
- ETON vs CLNE Comparison
ETON vs CLNE Comparison
Compare ETON & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CLNE
- Stock Information
- Founded
- ETON 2017
- CLNE 2001
- Country
- ETON United States
- CLNE United States
- Employees
- ETON N/A
- CLNE N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CLNE Natural Gas Distribution
- Sector
- ETON Health Care
- CLNE Utilities
- Exchange
- ETON Nasdaq
- CLNE Nasdaq
- Market Cap
- ETON 498.8M
- CLNE 574.5M
- IPO Year
- ETON 2018
- CLNE 2007
- Fundamental
- Price
- ETON $18.35
- CLNE $2.86
- Analyst Decision
- ETON Strong Buy
- CLNE Strong Buy
- Analyst Count
- ETON 3
- CLNE 5
- Target Price
- ETON $29.67
- CLNE $3.59
- AVG Volume (30 Days)
- ETON 249.9K
- CLNE 1.4M
- Earning Date
- ETON 11-06-2025
- CLNE 11-04-2025
- Dividend Yield
- ETON N/A
- CLNE N/A
- EPS Growth
- ETON N/A
- CLNE N/A
- EPS
- ETON N/A
- CLNE N/A
- Revenue
- ETON $58,181,000.00
- CLNE $420,579,000.00
- Revenue This Year
- ETON $105.25
- CLNE $3.49
- Revenue Next Year
- ETON $40.84
- CLNE $1.71
- P/E Ratio
- ETON N/A
- CLNE N/A
- Revenue Growth
- ETON 85.40
- CLNE 4.08
- 52 Week Low
- ETON $8.24
- CLNE $1.30
- 52 Week High
- ETON $23.00
- CLNE $3.67
- Technical
- Relative Strength Index (RSI)
- ETON 45.34
- CLNE 54.03
- Support Level
- ETON $18.00
- CLNE $2.81
- Resistance Level
- ETON $18.92
- CLNE $3.11
- Average True Range (ATR)
- ETON 0.83
- CLNE 0.13
- MACD
- ETON -0.12
- CLNE -0.01
- Stochastic Oscillator
- ETON 45.30
- CLNE 40.70
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.